New Delhi: 8 additional super speciality seats across five medical colleges have been approved by the National Medical Commission (NMC) for the academic year 2025-26, following decisions taken by its…
Vijayawada: Andhra Pradesh Health Minister Satya Kumar Yadav on Saturday emphasised the need to reduce the number of cesarean deliveries, noting that most of the deliveries took place in private…
Agartala: To enhance accessibility, transparency, and efficiency of healthcare services, the Tripura Government has initiated a significant digital health program by implementing the Integrated Health Management Information System (IHMIS) in…
Chandigarh: In a major crackdown, the Central Bureau of Investigation (CBI) has unearthed a multi-crore fraud involving fraudulent medical reimbursement claims under the Ex-Servicemen Contributory Health Scheme (ECHS). As per…
Recognizing the evolving understanding of pigmentation biology, Eris Lifesciences has launched DEMELAN® NEXA Serum, a next-generation melanophagy-focused brightening serum designed for the comprehensive management of recurrent melasma, and photo-aging. DEMELAN®…
Researchers have found that continuous glucose monitoring (CGM) may provide detailed insights into steroid-induced hyperglycemia (SIH), showing distinct patterns based on the type of steroid and patient demographics. Dexamethasone showed…
In the FINEARTS-HF Trial, the EMPEROR-Preserved Trial risk score showed broad applicability across outcomes. While baseline risk did not alter the relative treatment effect of Finerenone, higher-risk patients derived greater…
In a new post hoc analysis, tirzepatide was associated with a lower incidence of a composite cardiovascular and kidney outcome compared with Dulaglutide in patients with diabetes and established cardiovascular…
A recent study suggests that popular vitamin B3 (niacin) supplements-especially NAD⁺ precursors like NMN, NR, and NAM-may reduce the effectiveness of chemotherapy in pancreatic cancer. Millions of Americans take daily…
In children aged 3-12 years, low-dose atropine (SYD-101) significantly reduced myopia progression compared to placebo (0.77 D vs 1.07 D). The effect was even greater in rapid progressors (0.51 D…